Round and round the merry-go-round
Merckx index,
Merckx index said:
What is your source for this assertion?
Yeah, you keep asking this question, yet happily provide no source for your own assertions except, 'A small study...'.
I spent a number of hours reading peer-reviewed studies the other day (because I have access to online journals), had prepared a response with details, and for some reason when I went to post it, the forum had logged me out. Unfortunately I didn't save the material to a different doc on my computer. I'm not going to repeat the effort.
The issue is, there has not been nearly enough work done in the area of DEHP exposure across industries, products and in food contamination events to rule them out. All I'm saying is that - even if unlikely - it is still possible to be exposed to DEHP levels within the range of those experienced by transfused patients. Now, for a test to be robust, it MUST rule out other possibilities through serious measurements. That means, Tour participants must be measured for their exposure to DEHP (given its short half-life in the body), averages taken, audits of sources of DEHP apart from transfusion taken, and then a robust methodology worked out to come up with a relevant cut-off point for certain DEHP exposure due to transfusion.
How do we know what the average exposure of Tour riders is to DEHP? Segura has gone from measures of general population and athletes in one country, then transferred those results to a different country under different circumstances. That's ******** as a methodology. You could drive a truck through the holes in it.
Merckx index said:
It would be nowhere remotely close to the spike seen following transfusion. Japanese food levels are only 2-3x levels in Holland, for example, and 7-8 times those in Americans...there is some variation in levels ingested even in individuals in a particular country...But these fluctuations are considerably less than the spike of 10-20 times seen following transfusion, and which occurs within hours.
Japanese levels 7-8 times those of Americans...that's close to 10 times, I believe. Also, we're talking averages here, aren't we? And you know how averages work, don't you?
I've read Segura's study at least four times now, and the same problems keep raising their head - the authors simply assume the athletes were transfusing...and HE KNOWS NOTHING ABOUT THEIR MEDICAL OR ENVIRONMENTAL EXPOSURE! And there's only four of them!
Next, and in the study authors' own words,
Segura et al said:
In our study,medical treatments with PVC devices did
not increase the day-long concentrations of DEHP metabolites and, thus, they would not probably explain positive results. Nevertheless, the possibility of other sources of substantial DEHP exposure cannot be completely excluded.(p148, Transfusion 50(1) 2010)
Shall I point out that Segura et al say,
other sources of substantial DEHP exposure cannot be completely excluded?
Merckx index said:
I'm still waiting for you to provide a single study of non-transfused individuals with levels as high as those reported for transfusion.
Well just look at the link I posted. It's easily seen that some industry exposed individuals clearly have daily levels as high as transfused individuals.
See, the way this game works is, if you're trying to prove that high DEHP metobolites = blood doping, then you have to provide concrete evidence, not me. I'm the one who comes along and says, "The studies you are relying upon have methodological gaps and/or aren't definitive for x, y, and z reasons." Then you go back and find some more evidence that is much more robust. The burden of proof is on you, not me. I'm happy to agree with you that it *may,* just *may* indicate of blood-doping, but it isn't a definitive test by any stretch of the imagination.
Merckx index said:
The small study I cited long ago in which levels fluctuated, and a different method of urine collection was employed, is the only one I know.
Small studies are at best suggestive of a path of further investigation, no more. I can equally say that a recent study that I read argues that no way has there been sufficient testing in the area of DEHP exposure (e.g., in offices etc) to determine average levels in the general population.
So, I think we'll have to agree to disagree on this one. You want to suggest that the DEHP test is water-tight (probably proving Contador doped). ALL I'm saying is, no it ain't. I'm not trying to defend AC; not trying to say the test won't be able to be used in the future. ALL I'm saying is that, at the moment, it's not robust enough.